May 2024 Prescription Drug Affordability Board Meeting

• Date and time: May 20th, 2024 2:00 pm
• Address:

  Miller Senate Building, William Amoss Room, 4th Floor
  11 Bladen Street
  Annapolis, MD 21401
  United States

Public Comment

The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected]​ no later than the close of business on Wednesday, May 15, 2024, and provide:

1. Your name
2. Your address
3. The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.

Written Comment

The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please include in the subject line: May 2024 Board Meeting Comments. Please submit any written comments concerning this agenda no later than the close of business on Wednesday, May 15, 2024.

Agenda and Meeting Materials

• ​Agenda (Revised 5/15/2024)​ - PDF - 87.25 KB
• Minutes​ - PDF - 90.38 KB
• Presentation on In​put from the Stakeholder Council (Revised 5/17/2024) - PDF - 1.71 MB
  • ​Written Comments to the Stakeholder Council can be found here under the April 29th meeting​.
• May 20, 2024 Meeting ​Recording​​
• Written Comments Received on "Drugs Referred to the Stakeholder Council"​​​ - PDF - 17.27 MB
• Written Comments Received on "Therapeutic Alternatives"​ - PDF - 4 MB

Comments Received for May 20th Board Meeting:​

• Written Comment Packet - PDF - 3.26 MB

The following entities provided written comment in the above packet:​

• Melissa Lynn Abrams, MD, FAAD

• American Partnership for Eosinophilic Disorders

• Oluyomi Amoye- Consumer 

• AstraZeneca

• Baltimore-Washington Conference of the United Methodist Church

• Committee to Protect Health Care

• Delaware-Maryland Synod

• Amit Mickey Dhir, MSN, MBA, AGPCNP-C, AAHIVS

• Families USA- The Voice for Healthcare Consumers

• Gilead

• HIV+HEP Policy Institute

• Infectious Disease Care Center

• Susan Lovelace, MS, CRNP

• Partnership to Improve Patient Care

• Progressive Maryland

• Regeneron

• Value of Care Coalition

• Dr. Chikoti Wheat

• Brittany Yerkes, MS PA-C, AAHIVM

Comments Received for May 20th Board Meeting after deadline and not included in the packet above:

• ​Sanofi​ - PDF - 196.02 KB
• Baltimore ​Area Faith Community - PDF - 4.03 MB
• Baptist Ministers’ Night Conference of Baltimore & Vicinity - PDF - 125.42 KB
• Ministers Conference of Baltimore and Vicinity - PDF - 240.97 KB
• Unitarian ​Universalist Legislative Ministry of Maryland Health Care Lead Advocate​ ​ - PDF - 68.72 KB
• League of Women Voters - PDF - 200.26 KB
• Kaiser Permanente - PDF - 327.56 KB
• Suzanne Schlattman - PDF - 122.24 KB
• Sus​an W. Talbott - PDF - 125.28 KB